| 000 | 02548 a2200661 4500 | ||
|---|---|---|---|
| 005 | 20250516155639.0 | ||
| 264 | 0 | _c20131113 | |
| 008 | 201311s 0 0 eng d | ||
| 022 | _a1879-0852 | ||
| 024 | 7 |
_a10.1016/j.ejca.2013.05.020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Joyce F | |
| 245 | 0 | 0 |
_aA Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cSep 2013 |
||
| 300 |
_a2972-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCapsules |
| 650 | 0 | 4 | _aCarcinoma, Ovarian Epithelial |
| 650 | 0 | 4 |
_aDiarrhea _xchemically induced |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aFatigue _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 |
_aNeoplasms, Glandular and Epithelial _xdrug therapy |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPhthalazines _xadministration & dosage |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 | _aPoly(ADP-ribose) Polymerase Inhibitors |
| 650 | 0 | 4 |
_aQuinazolines _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Progesterone _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTolaney, Sara M | |
| 700 | 1 | _aBirrer, Michael | |
| 700 | 1 | _aFleming, Gini F | |
| 700 | 1 | _aBuss, Mary K | |
| 700 | 1 | _aDahlberg, Suzanne E | |
| 700 | 1 | _aLee, Hang | |
| 700 | 1 | _aWhalen, Christin | |
| 700 | 1 | _aTyburski, Karin | |
| 700 | 1 | _aWiner, Eric | |
| 700 | 1 | _aIvy, Percy | |
| 700 | 1 | _aMatulonis, Ursula A | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 49 _gno. 14 _gp. 2972-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2013.05.020 _zAvailable from publisher's website |
| 999 |
_c22876015 _d22876015 |
||